Aton Ra Partners Alnylam Pharmaceuticals, Inc. Transaction History

Aton Ra Partners

$50.1 Million
Q4 2023

A detailed history of Aton Ra Partners transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Aton Ra Partners holds 2,662 shares of ALNY stock, worth $718,606. This represents 1.02% of its overall portfolio holdings.

Number of Shares

2,662

Previous 2,935 9.3%

Holding current value

$718,606

Previous $519,000 1.93%

% of portfolio

1.02%

Previous 1.09%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$151.41 - $196.57 $41,334 - $53,663	-273 Reduced 9.3%	2,662 $509,000
Q3 2023 Oct 25, 2023	SELL	$170.77 - $211.65 $115,269 - $142,863	-675 Reduced 18.7%	2,935 $519,000
Q2 2023 Jul 18, 2023	SELL	$185.01 - $212.05 $29,231 - $33,503	-158 Reduced 4.19%	3,610 $685,000
Q1 2023 May 05, 2023	SELL	$182.66 - $235.53 $88,590 - $114,232	-485 Reduced 11.4%	3,768 $754,000
Q4 2022 Feb 02, 2023	SELL	$185.53 - $241.31 $329,501 - $428,566	-1,776 Reduced 29.46%	4,253 $1.01 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $5,957 - $9,976	-43 Reduced 0.71%	6,029 $1.21 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $422,553 - $594,038	-3,509 Reduced 36.62%	6,072 $886,000
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $18,949 - $25,912	149 Added 1.58%	9,581 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $119,350 - $156,548	748 Added 8.61%	9,432 $1.6 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $99,643 - $121,937	587 Added 7.25%	8,684 $1.64 Million
Q2 2021 Aug 12, 2021	SELL	$128.63 - $176.89 $1.56 Million - $2.14 Million	-12,113 Reduced 59.94%	8,097 $1.37 Million
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $1.63 Million - $2.25 Million	12,820 Added 173.48%	20,210 $2.85 Million
Q4 2020 Feb 19, 2021	BUY	$122.97 - $147.0 $908,748 - $1.09 Million	7,390 New	7,390 $960,000

Others Institutions Holding ALNY

# of Institutions

639

Shares Held

109M

Call Options Held

2.33M

Put Options Held

2.15M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.

Account